# A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

> clinical trial · VERIFIED · 2026-08-11

Status: RECRUITING · Sponsor: Intensity Therapeutics, Inc. · Condition: Sarcoma,Soft Tissue

- Company: Intensity Therapeutics, Inc.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06263231

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.